Knowledge (XXG)

Template:Antibiotics and chemotherapeutics for dermatological use

Source 📝

37: 30: 383: 462: 15: 222: 148: 230: 90: 50: 349: 387: 303: 120: 95: 265: 245: 127: 85: 54: 456: 397: 354: 255: 250: 235: 163: 159: 359: 313: 213: 184: 152: 100: 76: 58: 328: 283: 278: 194: 298: 189: 136: 116: 67: 46: 308: 293: 288: 273: 199: 174: 170: 323: 240: 141: 131: 425:
will show the template collapsed, i.e. hidden apart from its title bar.
390:), it is hidden apart from its title bar; if not, it is fully visible. 318: 333: 382:, meaning that if there is another collapsible item on the page (a 19: 433:
Antibiotics and chemotherapeutics for dermatological use
409:
Antibiotics and chemotherapeutics for dermatological use
449:
will show the template expanded, i.e. fully visible.
428: 404: 342: 264: 221: 212: 109: 75: 66: 393:To change this template's initial visibility, the 31: 8: 218: 72: 38: 24: 16: 377:initial visibility currently defaults to 394: 7: 388:table with the collapsible attribute 14: 1: 479: 463:Drug templates by ATC 231:Silver sulfadiazine 372: 371: 368: 367: 214:Chemotherapeutics 208: 207: 91:Chlortetracycline 51:chemotherapeutics 470: 448: 447: 443: 440: 437: 434: 431: 424: 423: 419: 416: 413: 410: 407: 396: 395:|state= 380: 375:This template's 350:Ingenol mebutate 219: 73: 40: 33: 26: 17: 478: 477: 473: 472: 471: 469: 468: 467: 453: 452: 445: 441: 438: 435: 432: 429: 421: 417: 414: 411: 408: 405: 384:navbox, sidebar 378: 373: 364: 338: 304:Podophyllotoxin 260: 204: 128:Aminoglycosides 121:Chloramphenicol 105: 96:Oxytetracycline 79:and derivatives 62: 44: 12: 11: 5: 476: 474: 466: 465: 455: 454: 451: 450: 426: 370: 369: 366: 365: 363: 362: 357: 352: 346: 344: 340: 339: 337: 336: 331: 326: 321: 316: 311: 306: 301: 296: 291: 286: 281: 276: 270: 268: 262: 261: 259: 258: 253: 248: 246:Sulfamethizole 243: 238: 233: 227: 225: 216: 210: 209: 206: 205: 203: 202: 197: 192: 187: 178: 177: 167: 166: 156: 155: 145: 144: 139: 134: 124: 123: 113: 111: 107: 106: 104: 103: 98: 93: 88: 86:Demeclocycline 82: 80: 70: 64: 63: 55:dermatological 45: 43: 42: 35: 28: 20: 13: 10: 9: 6: 4: 3: 2: 475: 464: 461: 460: 458: 427: 403: 402: 401: 400:may be used: 399: 391: 389: 385: 381: 361: 358: 356: 355:Metronidazole 353: 351: 348: 347: 345: 341: 335: 332: 330: 327: 325: 322: 320: 317: 315: 312: 310: 307: 305: 302: 300: 297: 295: 292: 290: 287: 285: 282: 280: 277: 275: 272: 271: 269: 267: 263: 257: 256:Sulfamerazine 254: 252: 251:Sulfanilamide 249: 247: 244: 242: 239: 237: 236:Sulfathiazole 234: 232: 229: 228: 226: 224: 220: 217: 215: 211: 201: 198: 196: 193: 191: 188: 186: 183: 180: 179: 176: 172: 169: 168: 165: 164:Virginiamycin 161: 160:Streptogramin 158: 157: 154: 150: 147: 146: 143: 140: 138: 135: 133: 129: 126: 125: 122: 118: 115: 114: 112: 108: 102: 99: 97: 94: 92: 89: 87: 84: 83: 81: 78: 74: 71: 69: 65: 60: 56: 52: 48: 41: 36: 34: 29: 27: 22: 21: 18: 392: 379:autocollapse 376: 374: 360:Tirbanibulin 314:Tromantadine 223:Sulfonamides 185:Fusidic acid 181: 153:Nadifloxacin 101:Tetracycline 77:Tetracycline 23: 329:Ibacitabine 284:Idoxuridine 279:Penciclovir 195:Tyrothricin 68:Antibiotics 47:Antibiotics 299:Resiquimod 266:Antivirals 190:Bacitracin 149:Quinolones 137:Gentamicin 117:Amphenicol 420:collapsed 398:parameter 309:Docosanol 294:Imiquimod 289:Edoxudine 274:Aciclovir 200:Mupirocin 175:Rifaximin 171:Rifamycin 457:Category 444:expanded 324:Lysozyme 241:Mafenide 142:Amikacin 132:Neomycin 319:Inosine 334:Lysine 182:other: 110:Others 439:state 415:state 386:, or 343:Other 57:use ( 53:for 49:and 59:D06 459:: 446:}} 430:{{ 422:}} 406:{{ 173:: 162:: 151:: 130:: 119:: 442:= 436:| 418:= 412:| 61:) 39:e 32:t 25:v

Index

v
t
e
Antibiotics
chemotherapeutics
dermatological
D06
Antibiotics
Tetracycline
Demeclocycline
Chlortetracycline
Oxytetracycline
Tetracycline
Amphenicol
Chloramphenicol
Aminoglycosides
Neomycin
Gentamicin
Amikacin
Quinolones
Nadifloxacin
Streptogramin
Virginiamycin
Rifamycin
Rifaximin
Fusidic acid
Bacitracin
Tyrothricin
Mupirocin
Chemotherapeutics

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.